Comparison of Three Urine Normalization Strategies for Mass Spectrometric Analysis in a Pediatric Asthma Model
DOI:
https://doi.org/10.21627/3p72dt97Keywords:
Asthma, Creatinine, Urine, Total Metabolome, ‘CHILD Cohort Study’Abstract
INTRODUCTION: Metabolomics studies the products of metabolism within a biological system to determine biomarkers for disease diagnosis. Metabolite values found in urine analysis require a method to normalize the data to account for the urine concentration. Creatinine (CRN) is a commonly used method of LC-MS-MS data normalization; however, CRN is affected by muscle mass and height in children. This could be a concern when comparing children’s samples across various age groups. Referencing creatinine-to-height (CRN/HT) is a possible strategy to correct for such a concern. Another approach is to reference each metabolite to the total concentration of the metabolites; a strategy termed the total metabolome (TM). METHODS: We evaluated age/height as a confounder in pediatric metabolomic data analysis, by comparing CRN, CRN/HT, or TM normalization in children between the ages of 3-13 with or without asthma (n=152). LC-MS-MS measured 41 metabolites in urine samples, which were normalized to the three methods. These metabolites were then used to differentiate asthma versus healthy children. RESULTS: CRN was affected by age unlike CRN/HT or TM. The metabolites selected to differentiate healthy and asthmatic children differed based on the normalization technique;10 metabolites were shared across models. Diagnostic accuracy was affected by the normalization strategy. CONCLUSION: Using CRN/HT or TM limits the variation seen across ages and was better than CRN alone. The normalization strategy for hydration affects model accuracy in pediatric research.
Published
Issue
Section
License
Copyright (c) 2026 The Author(s). Published by JMSACL (Journal of Mass Spectrometry and Advances in the Clinical Lab). Licensed under CC BY.

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.